Mesoblast (MESO) Cash from Financing Activities (2016 - 2023)

Mesoblast (MESO) posted quarterly Cash from Financing Activities of $38.8 million for Q2 2023, up 1848.96% year-on-year from $2.0 million in Q2 2022, and up 1625.27% on a QoQ basis from -$2.5 million in Q1 2023.

Mesoblast (MESO) Cash from Financing Activities (2016 - 2023) Analysis & Trends

Mesoblast (MESO) has reported Cash from Financing Activities for 8 consecutive years, with $38.8 million the latest figure, recorded in Q2 2023.

  • Quarterly Cash from Financing Activities rose 1848.96% year-over-year to $38.8 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $74.5 million (up 854.83% YoY) and the FY2025 annual result came in at $147.3 million, up 266.03% from the prior year.
  • Cash from Financing Activities improved to $38.8 million in Q2 2023 per MESO's latest filing, from -$2.5 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for MESO reached as high as $106.4 million in Q1 2021 and fell as low as -$2.9 million in Q4 2021.
  • A 5-year average of $17.8 million and a median of -$50500.0 in 2019 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2020 — Cash from Financing Activities soared 251518.18% — and 2021, when it tumbled 294.22%.
  • Year by year, Cash from Financing Activities stood at $48.2 million in 2019, then slumped by 101.54% to -$744000.0 in 2020, then slumped by 294.22% to -$2.9 million in 2021, then jumped by 31.4% to -$2.0 million in 2022, then soared by 2026.29% to $38.8 million in 2023.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $38.8 million, -$2.5 million, and -$2.0 million for Q2 2023, Q1 2023, and Q4 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Mesoblast 2.08 Bn 1.95 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 38.76 Mn
Jun 30, 2023 38.76 Mn
Mar 31, 2023 -2.54 Mn
Mar 31, 2023 -2.54 Mn
Dec 31, 2022 -2.01 Mn
Dec 31, 2022 -2.01 Mn
Sep 30, 2022 40.30 Mn
Sep 30, 2022 40.30 Mn
Jun 30, 2022 -2.22 Mn
Jun 30, 2022 -2.22 Mn
Mar 31, 2022 -2.57 Mn
Mar 31, 2022 -2.57 Mn
Dec 31, 2021 -2.93 Mn
Dec 31, 2021 -2.93 Mn
Sep 30, 2021 -2.15 Mn
Sep 30, 2021 -2.15 Mn
Jun 30, 2021 -2.24 Mn
Jun 30, 2021 -2.24 Mn
Mar 31, 2021 106.36 Mn
Mar 31, 2021 106.36 Mn